Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Cyclically Adjusted Book per Share: ¥3.15 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300039 Shanghai Kaibao Pharmaceutical Co Ltd SZSE:300039
80 GF Score
Price ¥5.41
GF Value ¥4.47
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted Book per Share?

Shanghai Kaibao Pharmaceutical Co SZSE:300039 +0.74% 80 Cyclically Adjusted Book per Share is ¥3.15 as of Jun. 2026. GuruFocus rates SZSE:300039 with a GF Score™ of 80/100 and a GF Value™ of ¥4.47 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shanghai Kaibao Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥4.096. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥3.15 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Shanghai Kaibao Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 8.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Shanghai Kaibao Pharmaceutical Co was 10.50% per year. The lowest was 7.80% per year. And the median was 8.75% per year.

As of today (2026-09-07), Shanghai Kaibao Pharmaceutical Co's current stock price is ¥5.41. Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥3.15. Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.72.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Kaibao Pharmaceutical Co was 5.34. The lowest was 1.34. And the median was 2.46.


Shanghai Kaibao Pharmaceutical Co  (SZSE:300039) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.41/3.15
=1.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Kaibao Pharmaceutical Co was 5.34. The lowest was 1.34. And the median was 2.46.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Shanghai Kaibao Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.19 2.43 2.64 2.81 3.04

Shanghai Kaibao Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 2.98 3.04 3.11 3.15

SZSE:300039 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SZSE:300039
80GF Score
Shanghai Kaibao Pharmaceutical Co Ltd SZSE:300039
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Kaibao Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Kaibao Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.096/116.0564*116.0564
=4.096

Current CPI (Jun. 2026) = 116.0564.

Shanghai Kaibao Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.024 102.400 2.294
201612 2.041 102.600 2.309
201703 2.125 103.200 2.390
201706 2.235 103.100 2.516
201709 2.200 104.100 2.453
201712 2.208 104.500 2.452
201803 2.301 105.300 2.536
201806 2.279 104.900 2.521
201809 2.330 106.600 2.537
201812 2.329 106.500 2.538
201903 2.373 107.700 2.557
201906 2.330 107.700 2.511
201909 2.421 109.800 2.559
201912 2.456 111.200 2.563
202003 2.507 112.300 2.591
202006 2.430 110.400 2.555
202009 2.458 111.700 2.554
202012 2.465 111.500 2.566
202103 2.520 112.662 2.596
202106 2.513 111.769 2.609
202109 2.902 112.215 3.001
202112 2.911 113.108 2.987
202203 3.070 114.335 3.116
202206 4.220 114.558 4.275
202209 3.534 115.339 3.556
202212 3.596 115.116 3.625
202303 3.935 115.116 3.967
202306 3.719 114.558 3.768
202309 3.653 115.339 3.676
202312 3.854 114.781 3.897
202403 3.612 115.227 3.638
202406 3.355 114.781 3.392
202409 3.684 115.785 3.693
202412 3.922 114.893 3.962
202503 4.024 115.116 4.057
202506 4.076 114.907 4.117
202509 4.345 115.471 4.367
202512 4.224 115.832 4.232
202603 4.470 116.303 4.461
202606 4.096 116.056 4.096

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥3.15 mean?
Shanghai Kaibao Pharmaceutical Co (SZSE:300039) has a Cyclically Adjusted Book per Share of ¥3.15 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Kaibao Pharmaceutical Co and its competitors.
Is Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Shanghai Kaibao Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥3.15. Overall, Shanghai Kaibao Pharmaceutical Co has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS?
Shanghai Kaibao Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥3.15 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Kaibao Pharmaceutical Co and its competitors. Shanghai Kaibao Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥3.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Kaibao Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Kaibao Pharmaceutical Co (SZSE:300039) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥4.47, compared to a current price of ¥5.41 — trading 21% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥3.15. Shanghai Kaibao Pharmaceutical Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shanghai Kaibao Pharmaceutical Co (SZSE:300039), the current Cyclically Adjusted Book per Share is ¥3.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Kaibao Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥5.41 is trading 21% above its estimated GF Value™ of ¥4.47. GuruFocus considers Shanghai Kaibao Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SZSE:300039:

  • Cyclically Adjusted Book per Share: ¥3.15
  • GF Value™: ¥4.47 vs. price of ¥5.41 (21% above fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the SZSE:300039 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Kaibao Pharmaceutical Co Business Description

Address 88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401
Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.
80GF Score

Get the complete analysis for SZSE:300039

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.41
Price
¥4.47
GF Value